Physician profile
Kamal Kishore
NPI 1215059977
$2,455.73
in general payments reported to CMS, 2019-2025
16 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $117 · 2021: $313 · 2022: $521 · 2023: $729 · 2024: $259 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $773.58 | 2019-2025 | Eylea Hd, Eylea |
| Astellas Pharma US INC | $277.66 | 2023-2025 | Izervay |
| Mallinckrodt Hospital Products INC. | $272.54 | 2020-2023 | Acthar |
| Novartis Pharmaceuticals Corporation | $206.11 | 2019-2021 | |
| Genentech USA, INC. | $200.12 | 2020-2023 | Vabysmo |
| Abbvie INC. | $158.39 | 2022-2025 | |
| Apellis Pharmaceuticals, INC. | $151.31 | 2023 | Syfovre |
| Allergan, INC. | $143.11 | 2019-2022 | |
| Alimera Sciences, INC. | $71.35 | 2023-2024 | Iluvien, Yutiq |
| Biogen, INC. | $51.08 | 2023 | |
| Eyepoint US, INC. | $40.64 | 2021-2023 | |
| Cardinal Health 108 LLC | $30.06 | 2022 | |
| Dutch Ophthalmic, USA | $23.72 | 2022 | |
| Optos, INC. | $22.80 | 2020 | |
| Mallinckrodt Enterprises LLC | $19.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamal Kishore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.